MicroRNA-222 promotes drug resistance to doxorubicin in breast cancer via regulation of miR-222/bim pathway

Resistance to doxorubicin (DOX) is the most common clinical problem in breast cancer therapy, and the underlying molecular mechanism remains to be investigated. MicroRNAs (miRNAs) exhibit important regulatory functions in various malignant tumors including breast cancer. The aim of the present study...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Biosci Rep
Main Authors: Dai, Hong, Xu, Ling-yun, Qian, Qi, Zhu, Qiu-wei, Chen, Wei-xian
Formáid: Artigo
Teanga:Inglês
Foilsithe: Portland Press Ltd. 2019
Ábhair:
Research Articles
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6629945/
https://ncbi.nlm.nih.gov/pubmed/31273056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20190650
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla